ProteinSimple IPO Advisory
Share this IPO Profile:
Smart Search
For IPO Boutique's "scale of 1 to 5" BUY rating on ProteinSimple, and our comprehensive analysis, click "
Buy Market Research".
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
ProteinSimple | PRTN - NASDAQ |
TBD |
$0.00 |
$0.00 | TBD | |
J.P. Morgan, BofA Merrill Lynch |
Co-Manager(s): Cowen and Company, Leerink Partners |
|
Filing(s): Filed 2014-05-01
|
About ProteinSimple (adapted from ProteinSimple prospectus):
Their goal is simply to help researchers gain a better understanding of proteins and their role in disease. They develop and commercialize proprietary systems and consumables for protein analysis that ultimately help reveal new insights into the true nature of proteins.
This description is adapted from ProteinSimple prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as ProteinSimple "PRTN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2025 IPO Boutique. All Rights Reserved